InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
8
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+15.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by DOBMEIER ERIC, Chairman & CEO. Director active across 4 companies, notably Chinook Therapeutics, INC.. In total, 28 disclosures have been recorded. Breakdown: 8 buys · 0 sell. Total volume traded: €361k. History available since 14 May 2021. The latest transaction was filed on 19 July 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations28 total
1,231 shares0Common StockSEC:0001415889-24-020057:0
5,000 shares0Common StockSEC:0001415889-24-019904:0
446,825 shares@ US$0.2268100.0% of flowCommon StockSEC:0000905148-23-001449:0
Ideal exit: 6 Aug 2024 (T+270)
301,138 sharesCommon StockSEC:0001209191-23-045417:0
57,000 shares0Common StockSEC:0001140361-23-028151:0
25,000 shares@ US$0.422.9% of flowCommon StockSEC:0001209191-23-025720:0
20,248 sharesCommon StockSEC:0001209191-23-009773:0
25,000 shares@ US$0.422.9% of flowCommon StockSEC:0001209191-23-006054:0
30,000 shares@ US$0.353.0% of flowCommon StockSEC:0001209191-22-061441:0
25,000 shares0Common StockSEC:0001209191-22-059418:0
30,796 sharesCommon StockSEC:0001209191-22-053303:0
20,500 shares0Common StockSEC:0001140361-22-024160:0
5,000 shares@ US$13.029520.2% of flowCommon StockSEC:0001209191-22-032707:0
Ideal exit: 19 Feb 2023 (T+270)
20,247 sharesCommon StockSEC:0001209191-22-009561:0
40,000 shares@ US$0.3510.2% of flowCommon StockSEC:0001209191-21-071297
40,000 shares@ US$0.354.1% of flowCommon StockSEC:0001209191-21-071297:0
30,796 sharesCommon StockSEC:0001209191-21-060113
30,796 sharesCommon StockSEC:0001209191-21-060113:0
2,000 shares@ US$12.006.8% of flowCommon StockSEC:0001209191-21-057315:0
Ideal exit: 17 Jun 2022 (T+270)
2,000 shares@ US$12.006.2% of flowCommon StockSEC:0001209191-21-057315
Ideal exit: 17 Jun 2022 (T+270)
7,000 shares@ US$11.737623.2% of flowCommon StockSEC:0001209191-21-052605:0
Ideal exit: 15 May 2022 (T+270)
7,000 shares@ US$11.737621.2% of flowCommon StockSEC:0001209191-21-052605
Ideal exit: 15 May 2022 (T+270)
20,000 shares@ US$0.351.7% of flowCommon StockSEC:0001209191-21-040659
20,000 shares@ US$0.351.9% of flowCommon StockSEC:0001209191-21-040659:0
11,000 shares0Common StockSEC:0001140361-21-020435:0
25 of 28 declarations
About DOBMEIER ERIC
Eric Dobmeier is an executive at Chinook Therapeutics, Inc.
